Skip to main content
Premium Trial:

Request an Annual Quote

Gene Network Sciences to Analyze Biomarker Data for Biogen Idec

NEW YORK (GenomeWeb News) – Gene Network Sciences will process clinical data from Biogen Idec to identify targets and biomarkers for inflammation, GNS said today.
 
GNS will use the data to develop a forward-simulation model that Biogen will then license.
 
GNS uses massively parallel supercomputers to search through “vast amounts of raw human biological data” for causes of disease and information about disease treatment, the company said.
 
Specifically, GNS will use its Reverse Engineering/Forward Simulation platform with genomic, genetic, and clinical data from Biogen “to generate and score billions of hypotheses to discover new drug targets and biomarkers rapidly,” the firm said in a statement.
 
Financial terms of the agreement were not released.
 

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.